Department of Kinesiology, School of Public Health, Indiana University, Bloomington, IN, USA.
Institute of Health Promotion and Sport Sciences, ELTE Eötvös Loránd University, Budapest, Hungary.
Eur J Sport Sci. 2020 Apr;20(3):293-301. doi: 10.1080/17461391.2020.1727021. Epub 2020 Feb 23.
Research over the past 15 years on the placebo effect has substantiated its contribution to the efficacy of established treatments for a range of clinical conditions and identified its underlying mechanisms. There is also evidence that placebo effects contribute to the performance benefits of many ergogenic aids, and that performance can worsen when dummy treatments are associated with expectations of a harmful outcome (i.e. nocebo effect). Unfortunately, the bulk of sport research involving placebos and nocebos continues to be hampered by outdated definitions and conceptualizations of placebo effects and their mechanisms. This has implications not only for research but also application, as nearly 50% of athletes report experiencing a beneficial placebo effect, and a similar proportion of coaches report providing placebos to their athletes. The objective of this paper is to attempt to stimulate research by presenting updated definitions of placebo and nocebo effects in the context of sport, describing their major mechanisms and, highlighting the importance of the psychosocial context on placebo effects in the sport setting.
过去 15 年来,对安慰剂效应的研究证实了它对一系列临床病症的既定治疗效果的贡献,并确定了其潜在机制。也有证据表明,安慰剂效应有助于许多运动补剂的表现提升,而当虚假治疗与对有害后果的预期相关联时(即反安慰剂效应),表现可能会恶化。不幸的是,涉及安慰剂和反安慰剂的大部分运动研究仍然受到安慰剂效应及其机制的过时定义和概念化的阻碍。这不仅对研究而且对应用都有影响,因为近 50%的运动员报告经历了有益的安慰剂效应,而类似比例的教练报告向他们的运动员提供了安慰剂。本文的目的是通过在运动背景下提出安慰剂和反安慰剂效应的更新定义来试图激发研究,描述它们的主要机制,并强调心理社会环境对运动环境中安慰剂效应的重要性。